SELECTED WRITINGS AND SPEECHES

Food and Drug Administration (FDA) Policy Issues

A Strong FDA is Good for America (PDF, 45K)

Integrating Recruitment into eHealth Patient Records (PDF, 142K)

Comprehensive Pharmacovigilance and eHealth Surveillance(PDF, 36KB)

OTC Medications, Advertising and The Public Health: A US Perspective (PDF, 39K)

Why Are Pharmaceuticals So Expensive? (PDF, 18K)

Strategic Planning, Coalition Development and Meeting Facilitation

Stakeholders’ Forum: Preventing Prescription Medicine Abuse, Misuse, and Diversion: A Role for All. National Council on Patient Information and Education (NCPIE) (PDF, 38K)

Alliance for Aging Research: Strategic Plan FY 2004-2006 (Available soon in PDF format. In the interim, contact Mr. Grossman for a copy)

Federal and State Government Relations

Anti-Addiction Medications: Making the Case for Incentives (PDF, 26K)

Commentary: A Good Law is Always at Risk (PDF, 28K)

Benchmarking Survey of Corporate State Governments Relations Program (PDF, 26K)

Health Care Financing Policy

Testimony before the Medicare Coverage Advisory Committee concerning authoritative drug compendia and coverage of treatments for rare diseases and conditions (PDF, 143K)

Yes, No, Maybe, Please Ask Again: The Frustrating Tale of Expensive Orphan Drugs Under Medicare Part D (PDF, 68K)

A Short Guide to Understanding Medicaid (PDF, 36K)

A Short Guide to Understanding the Olmstead Decision and Its Impact (PDF, 34K)

Food and Drug Administration (FDA) Advisory Committees

Preparing for an FDA Advisory Committee (PPT Slide Show) (PPT, 117K)

Case Study: Facing an FDA Advisory Committee Hearing (PDF, 19K)

Research on Advisory Committee Members as Part of FDA Advisory Committee Preparation (PDF, 26K)

Development and Management of Mock Panels as Part of FDA Advisory Committee Preparation (PDF, 26K)

To download the latest version of Adobe Acrobat Reader, click here.

© HPS Group, LLC: 2001-2007